Differences

This shows you the differences between two versions of the page.

--- home:starting:physician:reluctant [04.15.2019] – [Specific research] sallieq
+++ home:starting:physician:reluctant [04.26.2019] – [Specific research] sallieq
@@ Line 193: / Line 193: @@
-Olmesartan significantly reduced myocardial infarct size and improved LV contractility at a dose (3 mg/kg) with systemic vasodilating effects but not at a lower dose (0.3 mg/kg) without hemodynamic effects.(in rat)(({{pubmed>long:88888888}}))  PMID 88888888
+Olmesartan significantly reduced myocardial infarct size and improved LV contractility at a dose (3 mg/kg) with systemic vasodilating effects but not at a lower dose (0.3 mg/kg) without hemodynamic effects.(in rat)(({{pubmed>long:20074257}}))  PMID 20074257
 Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. (({{pubmed>long:19304450}}))   PMID 19304450
@@ Line 209: / Line 209: @@
-mg/kg olmesartan reduces the inflammatory process and bone loss in rats (({{pubmed>long:88888888}} ))
+mg/kg olmesartan reduces the inflammatory process and bone loss in rats (({{pubmed>long:23775504}} )) PMID 23775504

home/starting/physician/reluctant.txt · Last modified: 09.14.2022 by 127.0.0.1